View in EDS HTML Full Text PDF Full Text

Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors.

Saved in:
Bibliographic Details
Title: Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors.
Authors: Luo, Meiying1 (AUTHOR) luomeiying@imech.ac.cn, Wang, Xiaohuan2 (AUTHOR) wangxh0808@126.com, Yu, Guoji3 (AUTHOR) guojiyu52@gmail.com, Ji, Jing4 (AUTHOR) jingji09714@buaa.edu.cn, Li, Long1,5 (AUTHOR) lilong@lnm.imech.ac.cn, Song, Fan1,6 (AUTHOR) songf@lnm.imech.ac.cn
Source: Experimental Hematology & Oncology. 3/8/2025, Vol. 14 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-025-00624-9